Acute T-cell leukemia cells sensitive to vorinostat-induced cell death showed MYBL2 downregulation upon treatment, while resistant cells expressing the CDK inhibitor p16INK4A lost the ability to suppress MYBL2[139]. This evidence concerns the gene MYBL2 and T-cell acute lymphoblastic leukemia.